| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | Feb 01, 2024 | Sale | $8.70 | 19,122 | 166,435 | 360,616 | Feb 02, 2024, 04:06 PM | |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | CHIEF EXECUTIVE OFFICER | Jan 23, 2024 | Sale | $8.96 | 7,873 | 70,542 | 234,722 | Jan 25, 2024, 04:10 PM | |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Sep 05, 2023 | Sale | $14.71 | 4,455 | 65,533 | 242,595 | Sep 05, 2023, 08:10 PM | |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Feb 01, 2023 | Sale | $22.25 | 8,196 | 182,361 | 237,150 | Feb 02, 2023, 06:58 PM | |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Jan 24, 2023 | Sale | $21.50 | 6,442 | 138,503 | 147,846 | Jan 26, 2023, 04:05 PM | |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Jan 05, 2023 | Sale | $20.75 | 5,625 | 116,719 | 154,288 | Jan 06, 2023, 04:05 PM | |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Feb 10, 2022 | Sale | $27.84 | 4,832 | 134,523 | 159,913 | Feb 11, 2022, 04:05 PM | |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Jan 31, 2022 | Sale | $27.40 | 4,813 | 131,876 | 164,745 | Feb 02, 2022, 04:16 PM | |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Jan 24, 2022 | Sale | $24.98 | 7,873 | 196,668 | 131,710 | Jan 26, 2022, 04:33 PM | |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Jan 04, 2022 | Sale | $30.43 | 4,832 | 147,038 | 152,083 | Jan 06, 2022, 04:03 PM | |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Jan 05, 2022 | Sale | $29.95 | 12,500 | 374,369 | 141,722 | Jan 06, 2022, 04:03 PM | |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Aug 17, 2021 | Sale | $17.12 | 7,836 | 134,142 | 156,915 | Aug 17, 2021, 07:40 PM | |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Feb 08, 2021 | Sale | $31.58 | 4,813 | 151,995 | 156,813 | Feb 09, 2021, 04:28 PM | |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Feb 05, 2021 | Sale | $31.41 | 4,813 | 151,176 | 161,626 | Feb 09, 2021, 04:28 PM | |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Feb 03, 2021 | Sale | $28.91 | 2,406 | 69,557 | 148,939 | Feb 03, 2021, 09:29 PM | |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Feb 02, 2021 | Sale | $29.91 | 8,734 | 261,267 | 153,751 | Feb 02, 2021, 09:20 PM | |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Jan 05, 2021 | Sale | $26.65 | 3,438 | 91,623 | 91,257 | Jan 07, 2021, 06:29 PM | |
| TVTX | Travere Therapeutics, Inc. | Dube Eric M | Chief Executive Officer | Jan 06, 2021 | Sale | $27.01 | 3,438 | 92,860 | 87,819 | Jan 07, 2021, 06:29 PM | |
| RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Officer | Sep 21, 2020 | Sale | $19.28 | 10,805 | 208,319 | 96,260 | Sep 22, 2020, 09:15 PM | |
| RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Officer | Jan 07, 2020 | Sale | $13.94 | 3,750 | 52,275 | 46,250 | Jan 08, 2020, 08:49 PM | |
| RTRX | Retrophin, Inc. | Dube Eric M | Chief Executive Officer | Jan 08, 2020 | Sale | $15.14 | 3,750 | 56,775 | 42,500 | Jan 08, 2020, 08:49 PM |
Menu